Study protocol: Impact of COVID-19 on Breast Cancer Patients and Services in a UK region: protocol for a mixed methods study.

Background<br/>Globally, breast cancer screening, diagnosis and treatment services were significantly<br/>impacted by the COVID-19 pandemic. Locally, the Northern Ireland Cancer Registry<br/>(NICR) reported an 11% reduction in breast cancers diagnosed April-December 2020<br/>compared with the same period 2018−2019 despite an expected increase. This study<br/>aims to identify how the patient journey was impacted by the COVID-19 pandemic<br/>and how service provision can be improved.<br/>Methods<br/>Population-based quantitative data will be collected by NICR for individuals diagnosed with invasive breast cancer (ICD 10 code C50). Data on presentation, investigations, comorbidities (including COVID-19 infection), molecular markers, stage at<br/>diagnosis, treatment, and survival will be examined. Two time periods will be compared: March-December 2018 (pre-COVID-19 cohort) and March-December 2020<br/>(COVID-19 cohort). Analysis will include descriptive statistics, chi-square tests and<br/>ANOVAs. Patient experiences of living with breast cancer and interacting with the<br/>healthcare system during the pandemic (March 2020-April 2024) will be captured<br/>through an online, self-completed, anonymous cross-sectional international survey.<br/>Quality of life will be captured in the survey using the EQ-5D-3L. Detailed descriptive<br/>qualitative interviews will be undertaken to better understand the lived experience<br/>of breast cancer and recommend ways that services and support programs can<br/>PLOS One | https://doi.org/10.1371/journal.pone.0333288 September 29, 2025 2 / 9<br/>effectively meet the needs of this patient group. This study benefits from the inclusion<br/>of patient representatives who have been involved since the inception of this project.<br/>Discussion<br/>This study aims to quantify the impact of the COVID-19 pandemic on breast cancer<br/>patient outcomes in a UK region and make recommendations to improve patient care<br/>and outcomes in the short and long term.

Authors

Publication Details

Journal
Research Portal (Queen's University Belfast)
Published
2025-09-29
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study protocol: Impact of COVID-19 on Breast Cancer Patients and Services in a UK region: protocol for a mixed methods study.

Charlene M. McShane, P. Darragh, Shreeya Sengupta, Sinéad Teresa Hawkins et al.
Research Portal (Queen's University Belfast)
COVID-19 and healthcare impacts
article

Study protocol: Impact of COVID-19 on Breast Cancer Patients and Services in a UK region: protocol for a mixed methods study.

Charlene M. McShane, P. Darragh, Shreeya Sengupta, Sinéad Teresa Hawkins, Jamie Roebuck, Nicole Lowans, Gareth Irwin, Anna Gavin, Elizabeth Moss, Siobhan O'Neill, Ann McBrien, Damien; id_orcid 0000-0003-2053-7078 Bennett, Meenakshi Sharma, Lynne; id_orcid 0000-0003-4711-7305 Lohfeld, Helen Mitchell
article en

Abstract

Background<br/>Globally, breast cancer screening, diagnosis and treatment services were significantly<br/>impacted by the COVID-19 pandemic. Locally, the Northern Ireland Cancer Registry<br/>(NICR) reported an 11% reduction in breast cancers diagnosed April-December 2020<br/>compared with the same period 2018−2019 despite an expected increase. This study<br/>aims to identify how the patient journey was impacted by the COVID-19 pandemic<br/>and how service provision can be improved.<br/>Methods<br/>Population-based quantitative data will be collected by NICR for individuals diagnosed with invasive breast cancer (ICD 10 code C50). Data on presentation, investigations, comorbidities (including COVID-19 infection), molecular markers, stage at<br/>diagnosis, treatment, and survival will be examined. Two time periods will be compared: March-December 2018 (pre-COVID-19 cohort) and March-December 2020<br/>(COVID-19 cohort). Analysis will include descriptive statistics, chi-square tests and<br/>ANOVAs. Patient experiences of living with breast cancer and interacting with the<br/>healthcare system during the pandemic (March 2020-April 2024) will be captured<br/>through an online, self-completed, anonymous cross-sectional international survey.<br/>Quality of life will be captured in the survey using the EQ-5D-3L. Detailed descriptive<br/>qualitative interviews will be undertaken to better understand the lived experience<br/>of breast cancer and recommend ways that services and support programs can<br/>PLOS One | https://doi.org/10.1371/journal.pone.0333288 September 29, 2025 2 / 9<br/>effectively meet the needs of this patient group. This study benefits from the inclusion<br/>of patient representatives who have been involved since the inception of this project.<br/>Discussion<br/>This study aims to quantify the impact of the COVID-19 pandemic on breast cancer<br/>patient outcomes in a UK region and make recommendations to improve patient care<br/>and outcomes in the short and long term.

Research Portal (Queen's University Belfast)
Good health and well-being
Openalex Percentile: Top 27%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.